State of Science Summit- Bladder/Prostate: Chaired by Alicia Morgans, MD, MPH

Article

In Partnership With:

State of Science Summit- Bladder/Prostate: Chaired by Alicia Morgans, MD, MPH

State of Science Summit- Bladder/Prostate: Chaired by Alicia Morgans, MD, MPH

Speakers

  • Stephanie Berg, DO | Dana-Farber Cancer Institute
  • Bradley McGregor, MD | Dana-Farber Cancer Institute
  • Atish Choudhury, MD, PhD | Dana-Farber Cancer Institute
  • Praful Ravi, MB, BChir, MRCP | Dana-Farber Cancer Institute

Topics

  • Immunotherapy in the Management of mUC
  • Treating mUC with ADCS
  • mCRPC: Shift in Treatment Paradigm with PARP inhibitors
  • Recent Advances in mHSPC
  • PSMA Targeted Therapies

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Samer A. Srour, MB ChB, MS
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Samer A. Srour, MB ChB, MS
Samer A. Srour, MB ChB, MS
Petros Grivas, MD, PhD, professor, Clinical Research Division, Fred Hutchinson Cancer Center; professor, Division of Hematology and Oncology, University of Washington (UW) School of Medicine; clinical director, Genitourinary Cancers Program, UW Medicine
A panel of 5 experts on renal cell carcinoma
Chandler H. Park, MD, an expert on renal cell carcinoma
Haeseong Park, MD, MPH
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Jennifer Brown, MD, PhD